HESTERBIOBSEHester Biosciences LtdMediumNeutral
Announced Fri, 15 May · 12:22 IST

Intimation of receipt of requests for reclassification from Promoters to public category in accordance with SEBI listing Regulations

Promoter Stake Sell 1pctOwnership Changes View source PDF

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹1749.00
prior close
₹1942.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+1.4+0.7+0.0+1.6+3.8+5.2+7.8+8.2+21.8+11.7+18.8+37.4
Up moveDown movePending
AI summary

Hester Biosciences has received reclassification requests from two promoters, Mr. Ravin Gandhi and Ms. Bela Gandhi, who together hold 9.45% of the company's voting rights (Ravin: 4.74% or 403,320 shares; Bela: 4.71% or 400,635 shares). Both individuals have requested to be moved from the Promoter category to the Public category under SEBI's Regulation 31A. Ravin Gandhi has already resigned from the Board of Directors as of 12 May 2026. Bela Gandhi has stated she has not been involved in management for 12 years. Both confirm their holdings are passive investments with no control over company affairs. The company will process these requests following SEBI LODR Regulations.

Likely market impact

If approved, this reclassification will reduce the combined promoter group holding by approximately 9.45%, potentially affecting the overall promoter holding percentage and influencing shareholder dynamics.